Dey Indranil reported grant involving 28,000 shares of Bluejay Diagnostics, Inc. at $0.00 for $0 on Aug 17, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
President and CEO
President and CEO
Filed Aug 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
28,000Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
40,522Direct
Trade date
Aug 17, 2026Grant
Filed
Aug 18, 2026, 4:15 PM ET1-day reporting delay
Accession
0001123292-26-001124Code A · Transaction 2208
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

BJDX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BJDX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +49%1w ago +1%1d ago +8.2%
Returns since7d −2.1%30d −16%90d180d1y

Footnotes in full

F1: These shares represent restricted stock units granted by the board of directors of the issuer. F2: Lana Management & Business Research International, LLC is an entity owned by Mr. Indranil Dey and Ms. Svetlana Dey. Mr. Dey has voting and dispositive power over the shares held by such entity.